Apogee Therapeutics Inc (APGE)

Stock-Based Compensation

$57.63M

TTM · Period ending: · USD

APGE logo

APGE Stock-Based Compensation

Latest reported$57.63M
APGE Stock-Based Comp ($2.14M → $57.63M)
High-resolution chart · PNG

APGE stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Apogee Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
46,277,000
23,332,000
6,103,000
2,142,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.